Co-localization of endomorphin-2 and substance P in primary afferent nociceptors and effects of injury: a light and electron microscopic study in the rat

Authors

  • Katarina Sanderson Nydahl,

    1. Department of Anatomy, University of California San Francisco, San Francisco, CA 94143, USA
    2. Department of Physiology, University of California San Francisco, San Francisco, CA 94143, USA
    3. W.M. Keck Center for Integrative Neuroscience, University of California San Francisco, San Francisco, CA 94143, USA
    Search for more papers by this author
  • Kate Skinner,

    1. Department of Anatomy, University of California San Francisco, San Francisco, CA 94143, USA
    2. W.M. Keck Center for Integrative Neuroscience, University of California San Francisco, San Francisco, CA 94143, USA
    Search for more papers by this author
  • David Julius,

    1. Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA 94143, USA
    Search for more papers by this author
  • Allan I. Basbaum

    1. Department of Anatomy, University of California San Francisco, San Francisco, CA 94143, USA
    2. Department of Physiology, University of California San Francisco, San Francisco, CA 94143, USA
    3. W.M. Keck Center for Integrative Neuroscience, University of California San Francisco, San Francisco, CA 94143, USA
    Search for more papers by this author

: Dr A. Basbaum, 1Department of Anatomy, as above.
E-mail: aib@phy.ucsf.edu

Abstract

Endomorphin-2 (EM2) is a tetrapeptide with remarkable affinity and selectivity for the mu-opioid receptor. In the present study, we used double-fluorescence and electron microscopic immunocytochemistry to identify subsets of EM2-expressing neurons in dorsal root ganglia and spinal cord dorsal horn of adult rats. Within the lumbar dorsal root ganglia, we found EM2 immunoreactivity mainly in small-to-medium size neurons, most of which co-expressed the neuropeptide substance P (SP). In adult rat L4 dorsal root ganglia, 23.9% of neuronal profiles contained EM2 immunoreactivity and ranged in size from 15 to 36 µm in diameter (mean 24.3 ± 4.3 µm). Double-labelling experiments with cytochemical markers of dorsal root ganglia neurons showed that approximately 95% of EM2-immunoreactive cell bodies also label with SP antisera, 83% co-express vanilloid receptor subtype 1/capsaicin receptor, and 17% label with isolectin B4, a marker of non-peptide nociceptors. Importantly, EM2 immunostaining persisted in mice with a deletion of the preprotachykinin-A gene that encodes SP. In the lumbar spinal cord dorsal horn, EM2 expression was concentrated in presumptive primary afferent terminals in laminae I and outer II. At the ultrastructural level, electron microscopic double-labelling showed co-localization of EM2 and SP in dense core vesicles of lumbar superficial dorsal horn synaptic terminals. Finally, 2 weeks after sciatic nerve axotomy we observed a greater than 50% reduction in EM2 immunoreactivity in the superficial dorsal horn. We suggest that the very strong anatomical relationship between primary afferent nociceptors that express SP and EM2 underlies an EM2 regulation of SP release via mu-opioid autoreceptors.

Ancillary